annual working capital:
$2.34B+$416.11M(+21.61%)Summary
- As of today (May 29, 2025), SRPT annual working capital is $2.34 billion, with the most recent change of +$416.11 million (+21.61%) on December 31, 2024.
- During the last 3 years, SRPT annual working capital has risen by +$190.41 million (+8.85%).
- SRPT annual working capital is now at all-time high.
Performance
SRPT Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$1.83B-$514.83M(-21.98%)Summary
- As of today (May 29, 2025), SRPT quarterly working capital is $1.83 billion, with the most recent change of -$514.83 million (-21.98%) on March 1, 2025.
- Over the past year, SRPT quarterly working capital has dropped by -$29.21 million (-1.57%).
- SRPT quarterly working capital is now -21.98% below its all-time high of $2.34 billion, reached on December 31, 2024.
Performance
SRPT quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
SRPT Working capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +21.6% | -1.6% |
3 y3 years | +8.8% | -12.0% |
5 y5 years | +94.5% | -18.5% |
SRPT Working capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +21.6% | -22.0% | at low |
5 y | 5-year | at high | +94.5% | -22.0% | +0.8% |
alltime | all time | at high | >+9999.0% | -22.0% | >+9999.0% |
SRPT Working capital History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $1.83B(-22.0%) |
Dec 2024 | $2.34B(+21.6%) | $2.34B(+17.9%) |
Sep 2024 | - | $1.99B(-0.5%) |
Jun 2024 | - | $2.00B(+7.5%) |
Mar 2024 | - | $1.86B(-3.6%) |
Dec 2023 | $1.93B(-0.6%) | $1.93B(-3.7%) |
Sep 2023 | - | $2.00B(+1.3%) |
Jun 2023 | - | $1.97B(+1.2%) |
Mar 2023 | - | $1.95B(+0.7%) |
Dec 2022 | $1.94B(-9.9%) | $1.94B(-4.2%) |
Sep 2022 | - | $2.02B(+5.2%) |
Jun 2022 | - | $1.92B(-7.3%) |
Mar 2022 | - | $2.08B(-3.5%) |
Dec 2021 | $2.15B(+4.0%) | $2.15B(+18.7%) |
Sep 2021 | - | $1.81B(-1.5%) |
Jun 2021 | - | $1.84B(-3.5%) |
Mar 2021 | - | $1.91B(-7.9%) |
Dec 2020 | $2.07B(+71.8%) | $2.07B(+6.4%) |
Sep 2020 | - | $1.94B(-7.6%) |
Jun 2020 | - | $2.10B(-6.1%) |
Mar 2020 | - | $2.24B(+86.1%) |
Dec 2019 | $1.20B(-3.9%) | $1.20B(+5.0%) |
Sep 2019 | - | $1.15B(-9.4%) |
Jun 2019 | - | $1.27B(-17.5%) |
Mar 2019 | - | $1.53B(+22.5%) |
Dec 2018 | $1.25B(+9.8%) | $1.25B(+39.5%) |
Sep 2018 | - | $897.68M(-13.2%) |
Jun 2018 | - | $1.03B(-8.3%) |
Mar 2018 | - | $1.13B(-1.1%) |
Dec 2017 | $1.14B(+282.6%) | $1.14B(+71.4%) |
Sep 2017 | - | $665.14M(+104.9%) |
Jun 2017 | - | $324.63M(-15.2%) |
Mar 2017 | - | $382.68M(+28.4%) |
Dec 2016 | $298.05M(+83.7%) | $298.05M(-19.4%) |
Sep 2016 | - | $369.81M(+328.7%) |
Jun 2016 | - | $86.26M(-18.3%) |
Mar 2016 | - | $105.57M(-34.9%) |
Dec 2015 | $162.25M(-23.1%) | $162.25M(+92.1%) |
Sep 2015 | - | $84.44M(-41.1%) |
Jun 2015 | - | $143.43M(-9.9%) |
Mar 2015 | - | $159.14M(-24.6%) |
Dec 2014 | $210.93M(-10.2%) | $210.93M(-14.6%) |
Sep 2014 | - | $247.09M(-10.2%) |
Jun 2014 | - | $275.27M(+30.1%) |
Mar 2014 | - | $211.61M(-9.9%) |
Dec 2013 | $234.84M(+104.2%) | $234.84M(-1.9%) |
Sep 2013 | - | $239.32M(+197.4%) |
Jun 2013 | - | $80.47M(+10.3%) |
Mar 2013 | - | $72.94M(-36.6%) |
Dec 2012 | $115.02M(+367.9%) | $115.02M(-982.0%) |
Sep 2012 | - | -$13.04M(-181.0%) |
Jun 2012 | - | $16.10M(+108.9%) |
Mar 2012 | - | $7.71M(-68.6%) |
Dec 2011 | $24.58M(-406.6%) | $24.58M(-3.3%) |
Sep 2011 | - | $25.41M(-12.6%) |
Jun 2011 | - | $29.09M(-715.6%) |
Mar 2011 | - | -$4.72M(-41.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | -$8.02M(-145.0%) | -$8.02M(+452.7%) |
Sep 2010 | - | -$1.45M(-154.5%) |
Jun 2010 | - | $2.66M(-85.0%) |
Mar 2010 | - | $17.81M(+0.0%) |
Dec 2009 | $17.80M(+82.5%) | $17.80M(+28.2%) |
Sep 2009 | - | $13.89M(-808.9%) |
Jun 2009 | - | -$1.96M(-111.4%) |
Mar 2009 | - | $17.16M(+75.9%) |
Dec 2008 | $9.76M(-48.5%) | $9.76M(+8.5%) |
Sep 2008 | - | $8.99M(-34.4%) |
Jun 2008 | - | $13.72M(+3.8%) |
Mar 2008 | - | $13.22M(-30.3%) |
Dec 2007 | $18.96M(-38.4%) | $18.96M(+163.2%) |
Sep 2007 | - | $7.20M(-55.9%) |
Jun 2007 | - | $16.33M(-31.9%) |
Mar 2007 | - | $23.96M(-22.2%) |
Dec 2006 | $30.79M(-32.9%) | $30.79M(-17.0%) |
Sep 2006 | - | $37.11M(-13.4%) |
Jun 2006 | - | $42.84M(-11.8%) |
Mar 2006 | - | $48.56M(+5.8%) |
Dec 2005 | $45.91M(+155.8%) | $45.91M(+58.4%) |
Sep 2005 | - | $28.98M(-5.0%) |
Jun 2005 | - | $30.50M(-13.3%) |
Mar 2005 | - | $35.20M(+96.1%) |
Dec 2004 | $17.95M(-48.2%) | $17.95M(-20.1%) |
Sep 2004 | - | $22.45M(-18.3%) |
Jun 2004 | - | $27.48M(-20.1%) |
Mar 2004 | - | $34.41M(-0.7%) |
Dec 2003 | $34.64M(+126.7%) | $34.64M(+33.2%) |
Sep 2003 | - | $26.01M(-11.8%) |
Jun 2003 | - | $29.48M(+169.0%) |
Mar 2003 | - | $10.96M(-28.3%) |
Dec 2002 | $15.28M(-36.9%) | $15.28M(-15.6%) |
Sep 2002 | - | $18.11M(-31.2%) |
Jun 2002 | - | $26.31M(-21.2%) |
Mar 2002 | - | $33.38M(+37.8%) |
Dec 2001 | $24.23M(-22.9%) | $24.23M(-11.0%) |
Sep 2001 | - | $27.24M(-20.5%) |
Jun 2001 | - | $34.25M(+32.4%) |
Mar 2001 | - | $25.86M(-17.7%) |
Dec 2000 | $31.41M(+193.5%) | $31.41M(-15.0%) |
Sep 2000 | - | $36.95M(+289.3%) |
Jun 2000 | - | $9.49M(-30.5%) |
Mar 2000 | - | $13.66M(+27.7%) |
Dec 1999 | $10.70M(+37.2%) | $10.70M(+529.4%) |
Sep 1999 | - | $1.70M(-57.5%) |
Jun 1999 | - | $4.00M(-33.3%) |
Mar 1999 | - | $6.00M(-23.1%) |
Dec 1998 | $7.80M(-54.7%) | $7.80M(-24.3%) |
Sep 1998 | - | $10.30M(-27.0%) |
Jun 1998 | - | $14.10M(-10.8%) |
Mar 1998 | - | $15.80M(-8.1%) |
Dec 1997 | $17.20M(+537.0%) | $17.20M(-2.8%) |
Sep 1997 | - | $17.70M(+6.0%) |
Jun 1997 | - | $16.70M(+778.9%) |
Mar 1997 | - | $1.90M |
Dec 1996 | $2.70M | - |
FAQ
- What is Sarepta Therapeutics annual working capital?
- What is the all time high annual working capital for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual working capital year-on-year change?
- What is Sarepta Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly working capital year-on-year change?
What is Sarepta Therapeutics annual working capital?
The current annual working capital of SRPT is $2.34B
What is the all time high annual working capital for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual working capital is $2.34B
What is Sarepta Therapeutics annual working capital year-on-year change?
Over the past year, SRPT annual working capital has changed by +$416.11M (+21.61%)
What is Sarepta Therapeutics quarterly working capital?
The current quarterly working capital of SRPT is $1.83B
What is the all time high quarterly working capital for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly working capital is $2.34B
What is Sarepta Therapeutics quarterly working capital year-on-year change?
Over the past year, SRPT quarterly working capital has changed by -$29.21M (-1.57%)